SAN DIEGO, June 17, 2026 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB: OTLC) today announced the completion of key Phase 2 objectives in its joint manufacturing automation initiative with TechForce Robotics, Inc. (“TechForce”), advancing the commercialization of an artificial intelligence (“AI”) powered good manufacturing practices (“GMP”) manufacturing services platform (the “Platform”) at SAPU Bio, Oncotelic’s 45%-owned OEB-5 sterile injectable cGMP manufacturing joint venture.
Genius Group Cancels 20,000,000 Company Shares, equivalent to 16% of Public Float
Brings This Week’s Total Reduction in Issued Capital to 26.6 Million Shares, Equivalent to Approximately 22% of Public Float.
Clearlake-backed Quest Software Acquires Anetac to Advance Identity Security for the Agentic AI Era
Clearlake-backed Quest Software Acquires Anetac to Advance Identity Security for the Agentic AI Era, strengthening Quest’s Security Platform
Diginex Announces Extension of Long Stop Date for Proposed Acquisition of Resulticks
LONDON, June 17, 2026 (GLOBE NEWSWIRE) — Diginex Limited (NASDAQ: DGNX) (“Diginex” or the “Company”), a provider of ESG, sustainability, and compliance solutions to institutional and corporate clients, today announced that it has agreed with Resulticks Global Companies Pte. Limited (“Resulticks”) to extend the Long Stop Date under the Sale and Purchase Agreement relating to Diginex’s proposed acquisition of Resulticks from 12 June 2026 to 30 June 2026 for the purpose of attending to the satisfaction of the remaining conditions to completion.
Nexentis: Subsidiary MitoCareX Bio Successfully Completed Broad Analysis of SLC Transport Proteins to Support Discovery of Hard-to-Treat Cancers and Metabolic Diseases
Ness Ziona, Israel, June 17, 2026 (GLOBE NEWSWIRE) — Nexentis Technologies Inc. (NASDAQ: NXTS) (“Nexentis” or the “Company”), a drug discovery company that also invests in solar energy assets based on the RTB (Ready to Build) business model, today announced that its wholly owned subsidiary, MitoCareX Bio Ltd. (“MitoCareX”), today reported that it has completed a broad structural analysis of human SLC (Solute Carrier) transport proteins as part of its ongoing efforts to expand and refine its small-molecule discovery capabilities.
Diana Shipping Inc. Raises Offer to Acquire Genco Shipping & Trading to $27.34 Per Share Comprised of $24.80 in Cash and One Diana Share
Diana Shares Valued at $2.54 Per Share Based on Diana’s Volume-Weighted Average Price for the 30 Days Ended on June 16, 2026
DISQO Launches AI Search Lift, the First Product to Measure the Incremental Effect of Advertising on LLMs and AI Discovery
As Signal Loss accelerates across the consumer journey, DISQO helps advertisers close a growing measurement gap across LLM-driven discovery
As Signal Loss accelerates across the consumer journey, DISQO helps advertisers close a growing measurement gap across LLM-driven discovery
HowToRobot Announces Record Q1 Revenue, 94% Gross Margins, and Surge in Enterprise Automation Demand
– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES –
– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES –
New KAICIID Policy Paper Challenges Media to Rethink Its Role in Peacebuilding
Should Journalists Have an Active Role in Building Peace?
Should Journalists Have an Active Role in Building Peace?
Bezos Earth Fund Commits $26 Million to the World’s First Satellite Constellation Dedicated to the Global Wildfire Challenge
The first three of a 50-satellite constellation, FireSat will set into orbit this Summer and help detect fires before they burn out of control
The first three of a 50-satellite constellation, FireSat will set into orbit this Summer and help detect fires before they burn out of control
HMNC Brain Health appoints Dr. Bjørn Grønning as Chief Medical Officer
MUNICH, Germany, June 17, 2026 – HMNC Brain Health (“HMNC” or the “Company”), a clinical-stage neuroscience company, today announced the appointment of Dr. Bjørn Grønning as Chief Medical Officer (CMO), effective immediately, following the planned transition of Dr. Hans Eriksson.
Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026
Company to Conduct Partnering Meetings Focused on Oncology, Liver Disease and Inflammatory Disease
ARMLOGI HOLDING CORP. ADVANCES OPERATIONAL READINESS AND NETWORK CAPACITY INITIATIVES AHEAD OF SUMMER PEAK COMMERCE SEASON
WALNUT, CA, June 17, 2026 (GLOBE NEWSWIRE) — Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions related to warehouse management and order fulfillment, today provided an update on the operational readiness initiatives the Company has undertaken across its fulfillment network in preparation for the summer peak commerce season.
Step Pharma advances dencatistat into phase 2 clinical trial for essential thrombocythaemia
Saint-Genis-Pouilly, France, 17 June 2026 – Step Pharma (“the Company”), the global leader in CTPS1 inhibition for targeted cancer treatment, today announces that it has advanced dencatistat, the Company’s first-in-class, highly selective, oral CTPS1 inhibitor, into a phase 2 clinical trial for essential thrombocythaemia (ET), a rare clonal blood disorder characterised by overproduction of platelets and risk of thrombosis.
Europe’s Biggest Banking Deal in Years Is Getting Closer
Italian bank UniCredit is edging closer to its goal of taking over German rival Commerzbank, a landmark deal that would create a pan-European financial giant.
PIPPA Launches its Artist Portal, Inviting Professionals to Join the Platform and Be Compensated for their Time and Talent
The first AI animation platform built to pay artists rather than replace them publishes its rates
The first AI animation platform built to pay artists rather than replace them publishes its rates